approval
saveTIVICAY (DOLUTEGRAVIR SODIUM) — FDA approval
October 7, 2022updated 5mo ago
community read0 votes
Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 5
- approvalTRIUMEQ (ABACAVIR SULFATE) — FDA approvalOct 7, 2022
- approvalTIVICAY PD (DOLUTEGRAVIR SODIUM) — FDA approvalOct 7, 2022
- approvalTRIUMEQ PD (ABACAVIR SULFATE) — FDA approvalOct 7, 2022
- approvalDOVATO (DOLUTEGRAVIR SODIUM) — FDA approvalOct 7, 2022
- approvalJULUCA (DOLUTEGRAVIR SODIUM) — FDA approvalOct 7, 2022
comments(0)
5-min edit window · permanent after that